Mirxes Holding Company Limited has announced the signing of a strategic partnership with N Health, a healthcare solutions provider and member of the Bangkok Dusit Medical Services (BDMS) Group, Thailand's largest healthcare provider. The collaboration aims to introduce Mirxes' advanced microRNA (miRNA) cancer screening solutions, including GASTROClear™ for gastric cancer and LUNGClear™ for lung cancer, across nearly 60 hospitals within N Health's network. This partnership is expected to enhance early cancer detection and improve patient outcomes in Thailand and the wider Southeast Asian region, supporting broader access to early disease detection and contributing to improved standards of cancer care.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirxes Holding Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260109-11986411), on January 09, 2026, and is solely responsible for the information contained therein.